To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles

1. Motivational programme for family planning in South Indian plantations.
2. Multidisciplinary research project on contraceptive of herbal origin.
3. (Multiple correlation between the average number of contraceptive users and selected variables describing family planning worker.)
4. The Muslim view of family planning.
5. Mycoses and biphasic oral contraception. [Mycoses et contraception orale de type biphasique.]
6. Myocardial infarction in young women on oral contraceptives.
7. Myocardial infarction: its relationship to oral contraceptive agents.
8. N.H.S. family planning.
9. N.H.S. Family Planning.
10. National Family Planning Board, Malaysia.
11. National family planning communication programme in Bangladesh.
12. National family planning programs of 5 selected I.G.C.C. countries: Indonesia, Malaysia, the Philippines, Singapore and Thailand--Status report 1974.
13. National health insurance proposals: their effect on family planning and other preventive health services.
14. The natural birth control book.
15. Natural family planning in Australia: priorities, problems and coherent policies.
16. Natural family planning.
18. Natural family planning]
19. Natural methods of family planning.
20. Natural methods of family planning.
21. The need for family planning and population control in Canada.
22. The need for family planning services in the United States, 1974.
23. Need for more effective dissemination of birth control information.
24. Need for publicly financed family planning services as measured by seven area surveys.
25. The negative association between surgically confirmed functional ovarian cysts and use of oral contraceptives.
26. New "his or hers" contraceptive fails FPA pregnancy ra rate New "his or hers" contraceptive fails FPA pregnancy rate trial.
27. A new approach to estrogen-free contraception based on progesterone receptor blockage by mid-cycle administration of ethyl norgestrienone (R 2323)
28. New approaches to contraception.
29. A new audio visual educational tool for family planning.
30. New clinic activities and back-up services for non-clinic distribution o f contraceptives.
31. New coins for family planning campaign.
32. New contraceptives.
33. New d and dl norgestrel/ethinylestradiol low dose combination oral contraceptives.
34. New developments in contraception.
35. New developments in non-hormonal contraception. [Neue Entwicklungen der nicht hormonalen Empfangnisverhutung.]
36. New directions in family planning, community-based distribution of contraceptives in Thailand.
37. A new low dose norethindrone acetate (0.6 mg) ethinyl estradiol (30 mcg) combination oral contraceptive.
38. A new low-oestrogen, low-progestogen combined oral contraceptive.
39. New Zealand. (Family planning)
40. Niger. (Family planning)
41. Non-human primates in contraceptive research.
42. Nonclinical OC distribution is vital to world family planning.
43. The noncontraceptive effects of oral contraceptive drugs: the Kaiser-Permanente Study.
44. Norinyl 1 + 50 as an oral contraceptive.
45. A note on the demographic impact of contraception in a mathematical model of human reproduction.
46. Notes on methods of contraception.
47. Notes on the Danfa comprehensive rural health and family planning project: Ghana. (Memo)
48. Notes on the integration of family planning with health programs.
49. Notes on the revised family planning acceptor recording system.
50. Notes on vasectomy: a family planning method for males.
51. The nurse and family planning.
52. A nurse's view of the role of the physician in family planning.
53. Nurses in family planning.
54. Nursing's acceptance of the function of family planning counselor.
55. Nutrition and the need for family planning.
56. Nutrition, family planning and maternal and child health. [Nutricion, planificacion familiar y salud en la madre y en el nino.]
57. O-t-c contraceptives.
58. Observations on family planning.
59. Observations on the problem of contraception among young psychotics treated in an outpatient hospital. [Observations sur le probleme de la contraception chez des jeunes psychotiques traites dans un hopital de jour.]
60. The occurrence and course of hypertensive disease in users and nonusers of oral contraceptive drugs.
61. Occurrence of hepatic impairment in women jaundiced by oral contraceptives and in their mothers and sisters.
62. Ocular manifestations and complications following oral contraceptive administration. [Augenhintergrundsuntersuchung bei Ovulationshemmer-Einnahme?]
63. Oestrogen containing oral contraceptives and antithrombin 3 activity.
64. Oestrogen, headache and oral contraceptives.
65. On birth control.
66. On non-family planning methods of population control.
67. On the measurement of the effects of factors influencing acceptance of family planning.
68. One-hour glucose tolerance in relation to the use of oral contraceptive drugs.
69. One-year contraception with Norgestrienone subdermal silastic implants.
70. Opinion leadership for family planning in Korean rural villages.
71. Opinion leadership in family planning.
72. Oral coital contraception: effects of progestogens administered before coitus.
73. Oral contraception and cancer of the uterus and breast) [Contraception orale et cancers de l'uterus et du sein.]
74. Oral contraception and increased risk of cerebral ischemia or thrombosis.
75. Oral contraception and induced depressive states. [Contraception orale et etats depressifs induits.]
76. Oral contraception and sex ratio at birth.
77. Oral contraception and sex ratio at birth.
78. Oral contraception and sex ratio at birth. (Letter to the editor)
79. Oral contraception and sex ratio. (Letter)
80. Oral contraception can decrease the pituitary capacity to release gonadotrophins in response to synthetic LH-releasing-hormone.
81. Oral contraception, coitus, and cervical cancer: a review of the literature.
82. Oral contraception: a medical audit.
83. Oral contraception: potential hazards of hormone therapy during pregnancy.
84. Oral contraceptive activity of danazol in the rhesus monkey.
85. Oral contraceptive compounds and mammalian oocyte meiosis.
86. An oral contraceptive drug and gingival enlargement; the relationship between local and systemic factors.
87. Oral contraceptive for men.
88. Oral contraceptive medication and glucose metabolism: long-term treatment.
89. Oral contraceptive prescription requirements and commercial availability in 45 developing countries.
90. Oral contraceptive program in a rural area.
91. Oral contraceptive-induced electrolyte retention: vascular adjustments t o volume expansion.
92. Oral contraceptive-induced elevation of blood pressure in rats.
93. Oral contraceptive-induced salt appetite in rats.
94. An oral contraceptive.
95. Oral contraceptive/alpha-tocopherol interrelationships: 2.
97. Oral contraceptives and allergy.
98. Oral contraceptives and attempted suicide. [Contraceptifs oraux et tentative de suicide.]
99. Oral contraceptives and candidiasis.
100. Oral contraceptives and changes in the female body. [Les contraceptifs oraux et l'ecologie feminine.]
101. Oral contraceptives and chromosome segregation in oocytes of mice.
102. Oral contraceptives and congenital limb-reduction defects.
103. Oral contraceptives and female ecology. [Les contraceptifs oraux et l'ecologie feminine.]
104. Oral contraceptives and health.
105. Oral contraceptives and health.
106. Oral contraceptives and health.
107. Oral contraceptives and health.
108. Oral contraceptives and health.
109. Oral contraceptives and health.
110. Oral contraceptives and health.
111. Oral contraceptives and health. An interim report from the Oral Contraceptive Study of the Royal College of General Practitioners.
112. Oral contraceptives and health. (Letter)
113. Oral contraceptives and health: thromboembolic disease. (Letter)
114. Oral contraceptives and hypertension: a report from the Boston Collaborative Drug Surveillance Program.
115. Oral contraceptives and increased formation of soluble fibrin.
116. Oral contraceptives and liver cysts. [P-piller og leversvulster.]
117. Oral contraceptives and myocardial infarction. (Letter)
118. Oral contraceptives and plasma renin concentration.
119. Oral contraceptives and porphyria cutanea tarda.
120. Oral contraceptives and riboflavin nutrition.
121. Oral contraceptives and thromboembolism.
122. Oral contraceptives and thromboembolism. (Letter)
123. Oral contraceptives and vitamin nutrition.
124. Oral contraceptives and vitamins. [Preventivpiller och vitaminer.]
125. Oral contraceptives for men, soft IUD'S, leaving research and entering developmental stages at Population Research Center.
126. Oral contraceptives in Japan.
127. Oral contraceptives, ABO blood groups, and fibrin formation.
128. Oral contraceptives, allergy, pregnancy, and depression.
129. Oral contraceptives, female hormones, the renin axis and high blood pressure.
130. Oral contraceptives, plasma-lysolecithin, and platelet aggregation.
131. Oral contraceptives, pyridoxine, and depression.
132. Oral contraceptives: accidents and contraindications. [Les contraceptifs oraux: accidents et contre-indications.]
133. Oral contraceptives: considerations of safety in nonclinical distribution.
134. Oral contraceptives: ethinyl estradiol binds with higher affinity than mestranol to macromolecules from the sites of anti-fertility action.
135. Oral contraceptives: metabolic and nutritional effects.
136. Oral contraceptives: pills may protect against type of cyst.
137. Organization and motivation of human resources. (Report of the Regional Family Planning Management Seminar for Central America and Panama, Managua, Nicaragua, August 4-9, 1974)
138. Organizational aspects on contraceptive information. [Organisatoriska synpunkter pa preventivemedelsradgivning.]
139. Organizational characteristics and performance of family planning clinics.
140. Organizing for government intervention in family planning.
141. The outcome of pregnancy after failure of an intrauterine contraceptive device.
142. Ovarian morphology after administration of an oral contraceptive: an investigation in the rhesus monkey.
143. Ovarian morphology and pituitary gonadotrophins in serum during and after long-term treatment with oral contraceptives.
144. Ovarian pregnancy and the intrauterine contraceptive device.
145. Overcoming resistance in family planning.
146. Overview of the family planning evaluation project.
147. Oviduct study as a screening method for contraceptive steroids.
148. (Pakistan informal inspection report) IIS case No. 5703; Pakistan population program--family planning services.
149. Panama. (Family planning)
150. Pancreatitis from oral contraceptives.(Letter)
151. Panel presentation: family planning as an integrative focus in social work education.
152. Papua and New Guinea. (Family Planning)
153. Paramedical and lay paramedical prescription of oral contraceptives: an experiment in the Bicol region of the Philippines.
154. Paramedical personnel in family planning: a creative association. [Personal paramedico en planificacion familiar: una asociacion creadora.]
155. A parenteral monthly contraceptive. Preliminary report. [Un anticonceptivo mensual parenteral. Comunicacion preliminar.]
156. The participation of midwives in family planning in the Republic of China. (Author's transl)
157. Past legislation: legislation past and present on contraception, abortion and sex education. [Legislation passee: legislation pasee et presente sur la contraception, 1'avortment et l'education sexuelle.]
158. Pathenogenesis and prophylaxis of some complications in intrauterine contraception. [Patogenez nekotorykh oslozhnenii pri vnutrimatochnoi kontratseptsii i ikh profilaktika.]
159. Patient labeling of medroxyprogesterone acetate injectable contraceptive.
160. Patient labeling of medroxyprogesterone acetate injectable contraceptive; stay of effective date of final order. Subchapter D. Drugs for human use. Part 30. New drugs.
161. Patterns of fertility, anti-natal knowledge and practice: impact of a rural family planning program, Ishan Division, Nigeria, 1969-72.
162. A pediatric clinic delivers contraceptive services: one year of experience in a municipal hospital.
163. Perception and practice of birth control in a Ghanaian matrilineage.
164. Perception, acceptance and effects of contraceptives, sterilization, and abortion.
165. Perforation of the uterus by the copper-T and copper-7 intrauterine contraceptive devices.
166. Performance of family planning programs.
167. Pertamina Family Planning Programmes.
168. The pharmacology of contraceptive agents.
169. Philippines. (Family planning)
170. Phones prove worth in family planning.
171. Physiological aspects of vaginal contraception: a review.
172. Phytohaemagglutinin-induced lymphocyte transformation and circulating autoantibodies in women taking oral contraceptives.
173. Planned Parenthood develops family planning clinic model.
174. Planned parenthood in an unplanned world.
175. Planned parenthood-educational viewpoint.
176. Plasma concentration of free and non-TeBG bound testosterone in women on oral contraceptives.
177. Plasma estrogens, progesterone and FSH/LH ratio in normal and abnormal cycles and in cycles under oral contraceptive treatment.
178. Plasma renin activity, renin substrate and aldosterone during treatment with various oral contraceptives.
179. Plasma-tryptophan and oral contraceptives. (Letter)
180. Pleasure and contraception. [Plaisir et contraception.]
181. The politics of family planning in the Dominican Republic: public policy and the political process.
182. The politics of MCH and family planning. (Draft)
183. The politics of population: birth control and eugenics movement.
184. Polypoid cervicitis in cystic fibrosis patients receiving oral contraceptives.
185. Population and birth control.
186. Population and family planning in Costa Rica: An annotated bibliography. [Poblacion y planificacion familiar en Costa Rica: Una bibliografia comen tada.]
187. Population and family planning in developing countries: the employer's role.
188. Population and family planning in Iran.
189. Population and family planning programs: a factbook.
190. Population and family planning.
191. Population and family planning.
192. Population and family planning: an overview.
193. Population and family planning: the particulars of five nations.
194. Population education of Korea: Planned Parenthood Federation of Korea [PPFK]
195. Population education, family planning and the school curriculum.
196. A population family planning resource center: a community education service.
197. Population growth and future role of family planning in Korea.
198. A population-family planning resource center: a community educational service.
199. Population/family planning IEC activities at University of North Carolina, Chapel Hill.
200. Population/family planning orientation book.
201. Population/family planning programs and activities.
202. Population/family planning programs in Latin America-problems and prospects.
203. Possibilities of contraception , induction of abortion, or early induction of labor in cattle. [Moglichkeiten der Konzeptionsverhutung, der Abortusauslosung, oder der vorzeitigen Geburtseinleitung beim Rind.]
204. A possible mode of action of progestagen-only oral contraceptives.
205. Post coital contraception - follow-on to a pilot study.
206. Post-coital contraceptive effect of 2-Br-alpha-ergocryptine (CB-154) in the rat.
207. Postcoital contraception with diethylstilbestrol -- updated.
208. Postcoital contraception. [La contraception post-coitale.]
209. Postpartum contraception. [Anticoncepcion el el puerperio.]
210. Postpartum contraceptive methods.
211. Postpartum family planning in private practice: a baseline study.
212. Postwar movement and program for family planning in Japan.
213. The potential for paramedical personnel in family planning: and analysis based on the Department of Health, Education, and Welfare 5-year Plan for Family Planning Services.
214. Poverty and family planning.
215. Practical aspects of the national family planning programme. (South Africa)
216. The practical midwife in mother and child care and family planning: a manual for training and utilization. [La partera empirica en la salud maternoinfantil y la planificacion familiar: guia para su adiestramento y utilizacion.]
217. The practice of contraception by clients of the Kenyan Family Planning Program.
218. Pre-testing and evaluation of educational materials used in family planning programmes.
219. Pre-testing and evaluation of educational materials used in the family planning programme in India.
220. Pre-testing and evaluation of educational materials used in the family planning programme in Singapore.
221. Pre-testing and evaluation of educational materials used in the family planning programme in the Philippines.
222. Pre-testing and evaluation of educational materials used in the family planning programme in the Republic of Korea.
223. Preethi: a social marketing program for the advancement of family planning.
224. Preference for sons, desire for additional children, and family planning in Thailand.
225. Pregnancy and birth control counseling.
226. Pregnancy and gynecological conditions for diagnosis and management in family planning clinics.
227. Pregnancy and the intrauterine contraceptive device.
228. Pregnancy complicated by intrauterine contraceptive devices.
229. Preliminary cost-benefit calculations of Pakistan's family planning programme.
230. Preliminary experience with a new low-oestrogen content combined oral contraceptive.
231. Preliminary report on an epidemic model approach to the propagation of family planning ideas.
232. A preliminary report on the contraceptive use of subdermal implants containing norethindrone.
233. The preliminary report on the study of utilization of Mohtamyae in family planning program.
234. Preoperative discontinuation of contraceptives (cont.). (Letter to the editor)
235. Preschool child malnutrition--a case for family planning.
236. The present aspect of the family planning programme in Vietnam.
237. Previous mass media experience in contraception and family planning programs.
238. Principles and the practice of interviewing for family planning.
239. Principles of contraception.
240. Problems and approaches in educating individuals and groups in family planning.
241. Problems of contraception in young women. [Probleme der Kontrazeption bei weiblichen Jugendlichen.]
242. Problems posed by family planning in the Antilles. [Les problemes poses par le planification familiale aux Antilles.]
243. Procedure for breast examination in a family planning clinic.
244. A profile of adolescents in a family planning center.
245. Progestagen-only contraception and tubal pregnancies. (Letter to the editor)
246. Progestasert: a uterine therapeutic system for long-term contraception: 1. Philosophy and clinical efficacy.
247. Progestational agents and blood coagulation. 5. Changes induced by sequential oral contraceptive therapy.
248. Progestogen-only contraception and tubal pregnancies.
249. Progestogen-only contraception and tubal pregnancies.
250. Progestogen-only contraception and tubal pregnancies.
251. Progestogen-only oral contraception and ectopic gestation. (Letter)
252. Progestogens as contraceptives.
253. A program for family planning based on maternal/child health services.
254. Program in Population and Family Planning [at the] University of Michigan.
255. Programme of the Malaysian Trades Union Congress for promotion of family planning and population policies in the organised sector in Malaysia.
256. Progress in the development of the Progestasert (trademark) 65 progesterone therapeutic system for contraception.
257. Progress report on the five-year plan for family planning services and population research programs. Third progress report to the Congress of the United States, pursuant to Section 5, Public Law 91-572.
258. Progress report: DMPA for contraception.
259. Realistic pathways to fertility reduction in less developed countries: the prospect from the viewpoint of family planning programs.
260. Recent advances and evaluation of contraceptive methods. [Avances recientes y evaluacion de los metodos anticonceptivos.]
261. The recent bibliography of family planning and fertility behaviour in Japan.
262. Recommendations of the First National Conference on Family Planning.
263. Recurrence of venous thromboembolic disease and use of oral contraceptives.
264. Recurrent pneumococcal peritonitis associated with an intra-uterine contraceptive device.
265. Reflections on family planning.
266. Regional seminar on the status of women and family planning for countries of the Western Hemisphere. Santo Domingo, Dominican Republic, May 9-22, 1973.
267. Regional social security and family planning project for Latin America.
268. Registry for endometrial carcinoma in young women taking oral contraceptive agents.
269. Registry for endometrial carcinoma in young women taking oral contraceptive agents.
270. Regulation of contraception and termination of pregnancy in Rumanian legislation. [Reglementation de la contraception et de l'interruption de grossesse dans la legislation roumaine.]
271. Rehabilitation following interruption of pregnancy since the legalization of abortion. 1. Patient data, length of work incapacity, menstrual cycle, and effectiveness of contraceptive counseling. [Zur Frage der Rehabilitation nach Interruptic seit Legalisierung der Schwangerschaftsunterbrechung. 1. Patientstruktur, Dauer der Arbeitsunfaehigkeit, Zyklusverhalten, und Wirksamkeit der antikonzeptionellen Beratung.]
272. The relationship between program inputs, socioeconomic levels, and family planning performance: a regression analysis.
273. Relationship of pelvic infection to various types of contraception.
274. Relationships of ascorbic acid to pregnancy, and oral contraceptive steroids.
275. The relative importance of accessibility factors in family planning clinic utilization, National Acceptor Survey, Philippines, 1972.
276. The relative importance of governmental and commercial channels in the distribution of contraceptive supplies (a summary of the available data)
277. Reliability of reporting by women taking part in a prospective contraceptive study.
278. Relief of premenstrual symptoms, dysmenorrhea, and contraceptive tablet intolerance. A preliminary report.
279. Religious practice and attitudes toward divorce and contraception among Irish adults.
280. The renin-angiotensin system during oral contraceptive therapy and pregnancy.
281. Reorganized family planning.
282. Reorganized family planning.
283. Report and selected papers of the regional project on pre-testing and evaluation of educational materials used in family planning programmes.
284. Report of Task Force 1- administration of family planning programs in health services, 8-10 April, 1974.
285. Report of the fertility and family planning survey of eastern Uttar Pradesh.
286. Report on family planning.
287. Republic of Korea (Family planning)
288. Republic of Vietnam (Family planning)
289. Research in family planning in Pakistan.
290. The role of private family planning associations in population policies and programmes.
291. Role of religion in family planning acceptance.
292. Role of sterilisation in the program of family planning.
293. The role of the condom in planned parenthood programs.
294. The role of the family in postpartum family planning acceptance.
295. The role of the medical profession in family planning.
296. Role of the ophthalmologist in the use of oral contraceptives. [Mesto oftalmologa pri upotrebi kontraceptivnih sredstava.]
297. The role of the physician in family planning as seen by the public.
298. The role of the voluntary organization in encouraging use of voluntary sterilization in family planning and population programs.
299. Role of traditional birth attendants in family planning.
300. The role of Unesco in family planning communication.
301. Role perception and performance of lower class black men and women of Barbados and their contraceptive behavior.
302. Routine culture for gonococci in a family planning clinic. [Rutinemaessig podning for gonokokker i et kontraceptionsambulatorium.]
303. Rural family planning project: fourth annual report 1974.
304. Rural family planning project: third annual report 1973.
305. Rural Malaysians respond well to family planning.
306. Rwanda. (Family planning)
307. Sabah. (Family Planning)
308. Sale of contraceptives in Sweden. [Preventivmedelsforsaljningen i Sverige.]
309. Sales of contraceptives.
310. Says contraception is contramedicine.
311. School contraceptive programs should include counseling often.
312. Screening for mutagenic hazards of potential chemical contraceptives in the male.
313. Seasonality in human reproduction in Ghana: inquiry into conception correlates and implication for family planning programmes.
314. Senegal. (Family planning)
315. Serena: an alternative approach to family planning in Canada.
316. Serological survey for syphilis in a family planning clinic.
317. Serum growth hormone during menstrual cycle basal levels, responses to exercise, influence of oral contraceptives.
318. Serum immunoglobulin levels in women using intrauterine contraceptive devices.
319. Serum triglyceride in women with and without a predisposition to diabetes during short-term administration of a combined oral contraceptive.
320. Serum zinc levels in normal and anovulatory cycle and under oral contraceptive therapy. [Das Verhalten von Zink in normalen und anovulatorischen Zyklus und unter Einnahme von Ovulationshemmern.]
321. Severe hypertension with cardiac failure and nephrosclerosis after oral contraceptives. [Schwere Hypertonie mit Herzinsuffizienz und Nephrosklerose nach Einnahme oraler Antikonzeptiva.]
322. Sex preference of children and contraceptive use by women wanting no more children in Jakarta: 1968.
323. Sexual adjustment to contraception: oral contraceptives versus tubal ligation.
324. Sexual and contraceptive behavior of college females.
325. Sexual problems in family planning.
326. Sexuality and birth control: impact of outreach programming.
327. A short history of contraceptive methods.
328. A short review of the family planning programme of Sri Lanka.
329. Short-term costs and benefits of United States family planning programs.
330. Side effects of oral contraceptives containing norgestrel.
331. The side effects of oral contraceptives: can the patient be reassured?
332. Sierra Leone. (Family planning)
333. The significance of morphological changes of intrauterine contraceptive devices.
334. Silicone rubber: a drug-delivery system for contraceptive steroids.
335. Singapore (Family planning)
336. Six-monthly Depo-Provera injection as a contraceptive agent: its acceptability in Singapore.
337. Social and demographic characteristics of family planning acceptors in the three town area of the D.R. Sudan's capital.
338. Social and health related characteristics of women using oral contraceptives.
339. Social aspects of family planning: a study of 600 cases.
340. Social aspects of medical termination of pregnancy and family planning.
341. Social development in Africa: the case of family planning.
342. Social work and family planning: a conceptual framework.
343. The social work curriculum at graduate and undergraduate levels/a guide for integration of population/family planning content.
344. Socio-cultural aspects of family planning: an anthropological study at the village level.
345. Socio-cultural determinants in family planning.
346. Socio-medical aspects of family planning. [Aspectos sociomedicos de la planificacion familiar.]
347. The sociology of contraceptive practice.
348. Sociopolitical implications of family planning programs as an aspect of population policies and development planning in Africa.
349. Statistical evaluation of contraceptive methods.
350. Status of women and family planning.
351. Status of women and family planning. Report of the Special Rapporteur.
352. Sterilization and abortion within comprehensive Planned Parenthood programmes.
353. Sterilization and other family planning methods in the People's Republic of China.
354. Sterilization, abortion or contraception.
355. Steroidal hormonal contraceptives, vaginal smears and ovarian changes in rats. (Abstract only)
356. Stop at two: Mauritius takes family planning action.
357. A strategy for population education and family planning in the organized sector.
358. Stresses combination drugs' importance in contraception.
359. Stroke and myocardial infarction in a patient taking oral contraceptives.
360. Studies in family planning: India.
361. Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor 7.
362. Studies on the mutagenic effect of contraceptive drugs: 1. Induction of dominant lethal mutations in female mice.
363. A study of attitudes to contraceptives in a middle-class group of women.
364. A study of contraception as related to multiple unwanted pregnancies.
365. A study of inter-district variations in family planning acceptance in Uttar Pradesh.
366. Study of the contraceptive behavior of 64 patients hospitalized in a psychiatric ward in 1974. [Etude du comportemnt vis-a-vis de la contraception de 64 malades hospitalisees en psychiatrie, en 1974.]
367. A study of the effect of an oral contraceptive on blood coagulation factors, platelets and fibrinolytic activity.
368. A study on boy preference and family planning in Korea.
369. Study on the feasibility of distributing contraceptive supplies to encourage family planning practice.
370. Study on the feasibility of distributing contraceptive supplies to encourage family planning practice.
371. Study on the feasibility of distributing contraceptive supplies to encourage family planning practice. 3rd interim report on field activities: Summary tables on results of 1st follow-up visits. July 1-September 30, 1974.
372. Study on the interrelationship of the status of women and family planning (Addendum)
373. Study on the interrelationship of the status of women and family planning.
374. A study on the long-term effect of the intrauterine contraceptive device.
375. Subsequent fertility following contraception with long acting medroxyprogesterone acetate.
376. Success of various communication channels in the spreading of information on family planning. [Uspjesnost razlicitih kanala komunikacije u sirenju informacija o planiranju porodice.]
377. Suggestions for improving the interaction between breast feeding and family planning.
378. The supply of contraception.
379. The support system: the essence of contraceptive care for teenagers.
380. Surgical aspects of family planning (Males)
381. Surveillance summary: family planning services - United States, 1972.
382. Survey findings on family planning effects in the Philippines, 1968-73.
383. Survey of contraception in psychiatry. Preliminary results of 250 returns received from psychiatric hospitals. [Enquete sur la contraception en psychiatrie. Premiers resultats pour 250 responses provenant des hopitaux psychiatriques.]
384. Survey of family planning in the United States.
385. Survey of the knowledge and attitude of Korean university students regarding the two children movement and family planning practices.
386. Symposium: psychological research in family planning (introduction)
387. T.V. cassettes for education in family planning.
388. Tahiti (French Polynesia). (Family planning)
389. Tanzania. (Family planning)
390. Targets versus extension education: the family planning programme in Uttar Pradesh, India.
391. The task of health service in family planning in Yugoslavia. [Rad zdravstva na planiranju porodice u jugoslaviji.]
392. Tasks of the hospital physician in the area of family planning. [Die Aufgaben des Klinikers im Rahmen der Familienplanung.]
393. The teaching of family planning in the London, Ontario school system.
394. The teaching of family planning to nurses and midwives. [L'enseignement de la planification familiale aux infirmieres et aux sages-femmes.]
395. Techniques of family planning and evaluation.
396. Technological forecasting and research inputs in the area of birth control technology.
397. The technology of contraception -- 1.
398. The technology of contraception: 2.
399. The temperature rhythm method in family planning: its practical placement in a program. [Le test thermique en planification familiale: mise in place pratique d'un programme.]
400. Ten interviews about physicians and the population change. Abortion inevitable in developing countries. Is forced birth control near? [Tio intervjuas om lakarna och befolkningsfragan. Abort oundviklg i utvecklingslander. Ar barnbegransningstvang nara?]
401. A tentative model of resistance to innovation: the case of family planning.
402. Teratogenic screening methods and their application to contraceptive products.
403. Thai midwives brought into family planning.
404. Thailand (family planning)
405. Thailand country report on family planning.
406. Thailand national family planning program: can we do more?
407. Thailand's Chulalongkorn family planning services.
408. Thailand's National Family Planning Programme: synopsis of lecture and position paper.
409. Thailand. (Family planning)
410. Theories of attitude change and the "beyond family planning" debate: the case for the persuasion approach in population policy.
411. Third International Conference on Intrauterine Contraception, Cairo, Arab Republic of Egypt, December 12-14, 1974. (Abstracts only)
412. Thoughts on supply and demand in family planning.
413. Three agree. (Family planning)
414. Three judge panel to rule on contraceptive law.
415. Three views. (Planned parenthood)
416. Thromboembolic complications of pregnancy and oral contraceptives.
417. Thromboembolism and oral contraceptives.
418. Thromboembolism and oral contraceptives.
419. Thromboembolism and oral contraceptives.
420. Thromboembolism and oral-contraceptives - reply.
421. Thromboembolism, cancer and oral contraceptives.
422. Thyroid functions of women taking oral contraceptives.
423. Tonga (Family planning)
424. Tonga (Family planning)
425. Towards possible change: problems encountered in Philippine family planning program.
426. Traditional birth attendants (hilots) and modern family planning in Marinduque.
427. Traditional birth attendants: a key to rural maternal and child health and family planning services.
428. Traditional contraceptive techniques in Nigeria.
429. Training and evaluation of statistical personnel for the family planning programme.
430. Training facilities in demography, family planning and physiology of reproduction available in Latin America, the United States and Canada.
431. The training of "hilots" for family planning communication.
432. The training of nurse-midwives in family planning at Downstate Medical Center.
433. Training programme (Population and family planning, Latin America)
434. Translocation of intrauterine contraceptive devices.
435. Translocation of intrauterine contraceptive devices.
436. Translocation of intrauterine contraceptive devices. (Letter to the editor)
437. Translocation of intrauterine contraceptive devices. (Letter to the editor)
438. Translocation of intrauterine contraceptive devices. (Letter)
439. Trends in fertility, family size preferences, and practice of family planning: Taiwan, 1965-1973.
440. Trinidad and Tobago. (Family Planning)
441. Tubal pregnancies in women using progestagen-only contraception.
442. Tubo-ovarian actinomycosis associated with intrauterine contraceptive devices.
443. TV treatment of folk forms in family planning communication.
444. Twinning and oral contraceptives. (Letter to the editor)
445. U.S. Food and Drug Administration requirements for toxicity testing of contraceptive products.
446. Ultrastructural study of hepatic effects of a contraceptive steroid in baboons.
447. UNICEF assists family planning.
448. UNICEF-meeting to determine and coordinate medical/technical aspects of family planning supplies-April 29, 1974. [Memorandum]
449. Unmet needs in family planning: a synthesis.
450. The unwanted birth and the family planning service.
451. Ureteral dilation and hormones. A study of women taking oral contraceptives.
452. Use effectiveness of 6 month injections of DMPA as a contraceptive.
453. Use of an oestrogen-free pill (Ex Luton) for contraception.
454. Use of audio-visual aids in family planning.
455. The use of conjugated oestrogen in oral contraception.
456. Use of contraceptive services in periods of receipt and no-receipt of AFDC (Aid to Families with Dependent Children)
457. Use of contraceptives - changes in consumption and habits. [Preventivemedelsanvandning - forandringar i forbrukning och vanor.]
458. Use of contraceptives by a Brazilian population. [Emprego de anticoncepcionais por uma populacao brasileira.]
459. The use of dogs for studies of toxicity of contraceptive hormones.
460. Use of heat offers possibly reversible male contraception.
461. The use of hysterosalpingography and visceral, (transuterine)phlebography in intrauterine contraception. [Primenenie gisterosalpingografii i vistseralnot, chrezmatochnoi, flebogr afii pri vnutrimatochnoi kontratseptsii.]
462. Use of intrauterine contraceptive device: a review.
463. Use of oral and injectable hormonal contraceptives.
464. The use of progestogens as postcoital oral contraceptives.
465. The use of radio in family planning.
466. The use of rodents for studies of toxicity in contraceptive research.
467. The use of the IUD in family planning programmes: some comments.
468. Use-effectiveness of the condom in a selected family planning clinic population in the United Kingdom.
469. Use-effectiveness of the diaphragm in a selected family planning clinic population in the United Kingdom.
470. Useful methods of contraception.
471. Uterine progesterone contraception.
472. Uterine progesterone system (U.P.S.): a new form of intra-uterine contraception.
473. Uterine therapeutic system for long-term contraception: 2. Clinical correlates.
474. Utilization of traditional birth attendants (Kampong Bidans) for family planning in Malaysia, a working manual for nurses. 2nd ed.
475. Values, family planning, and development/implications for social work.
476. Variations de l'antithrombine III chez les femmes sous contraception orale. (Variations in antithrombin-III in women using oral contraceptives.)
477. The variegated Thai medical system as a context for birth control services.
478. Vasectomy and family planning. Advantages and consequences. [Vasectomia e planejamento familiar. Vantagens e consequencias.]
479. Vasectomy as a method of contraception. A review. [Vasektomi som kontraception. En oversigt.]
480. A view of family planning in the light of Muslim legislation.
481. A visual aid to the classification of oral contraceptives.
482. Vitamin A, pregnancy, and oral contraceptives.
483. Vitamin A, pregnancy, and oral contraceptives.
484. Vitamin A, pregnancy, and oral contraceptives.
485. Vitamin A, pregnancy, and oral contraceptives. (Letter to the editor)
486. Vitamin B6 status and requirements of the reference man, woman, and woman using oral contraceptives. (Abstract only)
487. Vitamin B6, depression, and oral contraception. (Letter to the editor)
488. Vitamin-B6 metabolism in women using oral contraceptives.
489. Volume and copper concentration of menstrual discharge from women employing Copper-7 and other types of contraceptives.
490. Voluntarism in family planning in Canada.
491. Voluntary effort in family planning: a brief history.
492. Voluntary motherhood: the beginnings of feminist birth control ideas in the United States.
493. A volunteer speaks: family planning motivational work.
494. Vulvovaginal candidosis and oral contraceptives.
495. W.H.O. and family planning.
496. Wanted: a fresh approach to Korea's family planning.
497. Western Samoa. (Family planning)
498. What contraceptive measures for women in their 40s and 50s?
499. What is the consensus on the minipill as a new contraceptive method? [Que faut-il penser de la minipill en tant que nouvelle methode contraceptive.]
500. What private physicians do about family planning.
501. The what, when, and why of currently available oral contraceptives.
502. When family planning education reaches a rural area: its determinants and consequences.